Low-Dose Ponatinib Is A Good Option In Chronic Myeloid Leukemia Patients Intolerant To Previous Tkis
Caocci, Giovanni;
2020-01-01
File | Size | Format | |
---|---|---|---|
LOW-DOSE PONATINIB IS A GOOD OPTION IN CHRONIC MYELOID LEUKEMIA PATIENTS INTOLERANT TO PREVIOUS TKIs .pdf Solo gestori archivio
Type: versione pre-print
Size 957.76 kB
Format Adobe PDF
|
957.76 kB | Adobe PDF | & nbsp; View / Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.